stockrowPrecision BioSciences, Inc. (DTIL) vs Century Therapeutics, Inc. (IPSC)
- Precision BioSciences, Inc. DTIL 10.75 +8.92%
- Century Therapeutics, Inc. IPSC 1.69 +11.92%
Precision BioSciences, Inc. and Century Therapeutics, Inc. are both Biotechnology companies. Precision BioSciences, Inc. and Century Therapeutics, Inc. are of similar size ($275.7M and $273.4M). Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against −11.9%. Across the 13 metrics below, Century Therapeutics, Inc. leads on 7 and Precision BioSciences, Inc. on 6.
Valuation
Profitability
| Metric | DTIL | IPSC | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (112.69%) | (49.65%) | (51.96%) |
| Return on assets | (36.04%) | (38.41%) | (46.06%) |
| Return on invested capital | 0.00% | (64.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack